Curevac Nv Stock Performance
| CVAC Stock | USD 4.66 0.01 0.21% |
The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. CureVac NV returns are very sensitive to returns on the market. As the market goes up or down, CureVac NV is expected to follow. At this point, CureVac NV has a negative expected return of -0.22%. Please make sure to confirm CureVac NV's maximum drawdown, kurtosis, day median price, as well as the relationship between the potential upside and daily balance of power , to decide if CureVac NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return 3.32 | Five Day Return 4.94 | Ten Year Return (91.65) | All Time Return (91.65) |
1 | Why CureVac N.V. stock is a value investor pick - July 2025 Catalysts Entry and Exit Point Strategies - newser.com | 10/29/2025 |
2 | Alpine Associates Management Inc. Makes New Investment in CureVac N.V. CVAC - MarketBeat | 11/04/2025 |
3 | Twist Bioscience Reports Q4 Loss, Tops Revenue Estimates | 11/14/2025 |
4 | How CureVac N.V. stock performs during Fed tightening cycles - Portfolio Gains Summary Risk Managed Investment Entry Signals - newser.com | 11/19/2025 |
5 | CureVac Nasdaq Index Captures RD Expansion | 11/24/2025 |
6 | Carlson Capital L.P. Makes New Investment in CureVac N.V. CVAC - MarketBeat | 11/28/2025 |
7 | CureVac N.V. ABullCase Theory | 12/04/2025 |
8 | How institutional buying supports CureVac N.V. stock - 2025 Price Targets Free Community Supported Trade Ideas - | 12/19/2025 |
9 | CureVac Reaches New 12-Month High Whats Next | 12/30/2025 |
| Begin Period Cash Flow | 402.5 M | |
| Total Cashflows From Investing Activities | -18.4 M |
CureVac NV Relative Risk vs. Return Landscape
If you would invest 543.00 in CureVac NV on October 7, 2025 and sell it today you would lose (79.00) from holding CureVac NV or give up 14.55% of portfolio value over 90 days. CureVac NV is currently does not generate positive expected returns and assumes 2.402% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than CureVac, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CureVac NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CureVac NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as CureVac NV, and traders can use it to determine the average amount a CureVac NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0913
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CVAC |
Based on monthly moving average CureVac NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CureVac NV by adding CureVac NV to a well-diversified portfolio.
CureVac NV Fundamentals Growth
CureVac Stock prices reflect investors' perceptions of the future prospects and financial health of CureVac NV, and CureVac NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CureVac Stock performance.
| Return On Equity | 0.4 | ||||
| Return On Asset | 0.24 | ||||
| Profit Margin | 1.82 % | ||||
| Operating Margin | 5.73 % | ||||
| Current Valuation | 600.19 M | ||||
| Shares Outstanding | 225.17 M | ||||
| Price To Book | 1.03 X | ||||
| Price To Sales | 14.86 X | ||||
| Revenue | 535.18 M | ||||
| Gross Profit | 65.99 M | ||||
| EBITDA | 209.69 M | ||||
| Net Income | 190.88 M | ||||
| Cash And Equivalents | 540.87 M | ||||
| Cash Per Share | 2.85 X | ||||
| Total Debt | 38.97 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 3.61 X | ||||
| Book Value Per Share | 5.65 X | ||||
| Cash Flow From Operations | 101.85 M | ||||
| Earnings Per Share | 0.67 X | ||||
| Market Capitalization | 1.05 B | ||||
| Total Asset | 802.83 M | ||||
| Retained Earnings | (1.4 B) | ||||
| Working Capital | 454.07 M | ||||
About CureVac NV Performance
By analyzing CureVac NV's fundamental ratios, stakeholders can gain valuable insights into CureVac NV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CureVac NV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CureVac NV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 2.15 | 2.04 | |
| Return On Tangible Assets | 0.19 | 0.20 | |
| Return On Capital Employed | 0.22 | 0.23 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 0.21 | 0.22 |
Things to note about CureVac NV performance evaluation
Checking the ongoing alerts about CureVac NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CureVac NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CureVac NV generated a negative expected return over the last 90 days | |
| CureVac NV is unlikely to experience financial distress in the next 2 years | |
| CureVac NV has a strong financial position based on the latest SEC filings | |
| Latest headline from thelincolnianonline.com: CureVac Reaches New 12-Month High Whats Next |
- Analyzing CureVac NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CureVac NV's stock is overvalued or undervalued compared to its peers.
- Examining CureVac NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CureVac NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CureVac NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CureVac NV's stock. These opinions can provide insight into CureVac NV's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |